DCT

2:16-cv-04344

Valeant Pharma Luxembourg SARL v. Actavis Laboratories Ut Inc

General

Filed

07/15/16

Cause of ActionPatent Infringement

SectorBiotech

Status

Closed (06/05/18)

Patent Owner

NPE (W)

PACER2:16-cv-04344

CourtD. New Jersey

Judge	Period	PO Win Rate
Jose L. Linares	--	62%

Plaintiff

Party

Name	Ratings
Valeant Pharmaceuticals Luxembourg SARL NPE	L3A
Valeant Pharmaceuticals North America LLC NPE	L3A

Attorney

Name	Ratings
Finnegan Henderson Farabow Garrett & Dunner LLP	L5A
Justin J. Hasford	L5A
Bryan C. Diner	L5C
Christine Yang	L5E
Esther H. Lim	L3E
Pepper Hamilton LLP	L5A
Melissa A. Chuderewicz	L4A
GibbonsLocal	L3B
J. Brugh Lower	L2D
William P. Deni, Jr.	L2E
Lauren B. Cooper	L1-- --
Cymetra M. Williams	L1-- --
Attorney at LawLocal	---- --
Yoonhee Kim	---- --

Defendant

Party

Name	Ratings
Actavis Laboratories Ut Inc	L5E
Actavis LLC	L5E
Allergan USA Inc	L5E
Actavis Inc	L5E

Attorney

Name	Ratings
Kirkland & Ellis LLP	L5B
Amanda J. Hollis	L5B
Thomas F. Fleming	L5D
Sarah K. Tsou	L4E
Christopher T. Jagoe	L4E
Brian Verbus	L2D
Rachael Morgan	---- --
Goodwin Procter LLP	L4C
William G. James, II	L5D
Brigid M. Morris	L4D
Brian J. Robinson	L4E
Jenny J. Zhang	L4E
Axinn Veltrop Harkrider LLP	L2E
Chad A. Landmon	L5E
Thomas K. Hedemann	L4E
Gregory J BevelockLocal	L1D
Gregory J. Bevelock	L1D